Cambridge Healthtech Institute’s 7th Annual

Accelerating Analytical Development

Optimizing the Speed and Efficiency of Key Analytical Steps in Biotherapeutic Development

August 26-27, 2020


Research for this meeting revealed that industry analytical groups are facing increased pressure to deliver key analytical studies faster than ever before – and at lower costs. Cambridge Healthtech Institute’s 7th Annual Accelerating Analytical Development conference offers a best practices forum in which industry scientists and managers can exchange ideas on strategies, new technologies and the integration of analytical methods in support of these goals. The conference will address the most important roles of the analytical function from early development through GMP release testing and provide insights on how different organizations are addressing these challenges. Proposed presentations should offer case studies of strategies, best practices and novel solutions applied in accelerating and optimizing analytical support of biotherapeutic development programs.


Coverage will include, but is not limited to:


  • Predictive Analytics
    • Modeling basic sequences to screen potential liabilities
    • Scale-up of predictive analytics
    • When predictions didn’t work out as planned; what have we learned?
  • Automation and Emerging Technologies
    • Continuous analytical studies; support for continuous production processes
    • The evolution of automated analytical systems; training robots new tricks
    • Workflow case studies for automation and high throughput methods
  • Method Development and Validation
    • Evaluation and implementation of alternatives to legacy analytical technologies
    • New technologies for development of cell-based assays
    • Retrospective case studies from marketed products; the development and evolution of methods used at each stage of development
  • Analytical Development Challenges
    • Drug combinations; mixtures, co-formulations, device considerations
    • New instrument combinations incorporating mass spectrometry
    • The challenges of platforming and accelerating analytics for complex molecules
  • Big Data in Analytical Development
    • Analytical impacts of process digitalization
    • Benchtop analysis of large and complex datasets
    • Developing and applying a historical knowledge base in analytical development
  • Regulatory Trends and Impacts
    • Compliance issues for integrity of analytical data
    • Implementing multi-attribute methods (MAM)
    • New standards and regulatory guidances


* The program is subject to change without notice, due to unforeseen reason.

Premier Sponsors: